William Brown

16PUBLICATIONS
66CO-AUTHORS
Nanotoxicology, health and safetyRegenerative medicine (incl. stem cells)Predictive and prognostic markersChiropracticMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 25, 2026
Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries.

|Dec 08, 2025
The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy.

Gioia Riboni-Verri, Christopher E McMurran, Trisha Mukherjee

|Nov 27, 2025
Towards primary prevention of multiple sclerosis.

Ruth Dobson, Karim L Kreft, Benjamin M Jacobs

|Feb 26, 2025
Exploratory analysis of biological age measures in a remyelination clinical trial.

Christopher E McMurran, Ermelinda de Meo, Nick G Cunniffe

|Aug 01, 2024
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.

Izanne Roos, Sifat Sharmin, Charles Malpas

|Mar 01, 2024
Bexarotene leads to durable improvements in visual evoked potential latency: A follow-up study of the Cambridge Centre for Myelin Repair One trial.

Christopher E McMurran, Trisha Mukherjee, J William L Brown

Pageof 3

Frequent Collaborators

5 joint publications

Declan T Chard

4 joint publications

Nick G Cunniffe

4 joint publications

Alasdair J Coles

4 joint publications

Christopher E McMurran